Gene · 8932
Papers2,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance. | Sci Rep | 2023 | 37031216 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| The role of long non-coding RNA in abdominal aortic aneurysm. | Front Genet | 2023 | 37007957 | PubTator, text mining | PubMed |
| TRABID overexpression enables synthetic lethality to PARP inhibitor via prolonging 53BP1 retention at double-strand breaks. | Nat Commun | 2023 | 37002234 | PubTator, text mining | PubMed |
| Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway. | Lab Invest | 2023 | 36990154 | PubTator, text mining | PubMed |
| Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. | Genes (Basel) | 2023 | 36980849 | PubTator, text mining | PubMed |
| Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia. | Genes (Basel) | 2023 | 36980827 | PubTator, text mining | PubMed |
| New Approaches to Targeting Epigenetic Regulation in Bladder Cancer. | Cancers (Basel) | 2023 | 36980741 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer. | Cancers (Basel) | 2023 | 36980520 | PubTator, text mining | PubMed |
| Chemical Inhibitors Targeting the Histone Lysine Demethylase Families with Potential for Drug Discovery. | Epigenomes | 2023 | 36975603 | PubTator, text mining | PubMed |
| miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma. | Clin Exp Med | 2023 | 36961677 | PubTator, text mining | PubMed |
| Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. | Front Immunol | 2023 | 36949947 | PubTator, text mining | PubMed |
| CircRANBP17 modulated KDM1A to regulate neuroblastoma progression by sponging miR-27b-3p. | Open Med (Wars) | 2023 | 36941992 | PubTator, text mining | PubMed |
| Transcriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages. | Immune Netw | 2023 | 36911799 | PubTator, text mining | PubMed |
| Analysis of gene expression profiles in Alzheimer's disease patients with different lifespan: A bioinformatics study focusing on the disease heterogeneity. | Front Aging Neurosci | 2023 | 36909942 | PubTator, text mining | PubMed |
| Parental Preconception and Pre-Hatch Exposure to a Developmental Insult Alters Offspring's Gene Expression and Epigenetic Regulations: An Avian Model. | Int J Mol Sci | 2023 | 36902484 | PubTator, text mining | PubMed |
| Zinc Finger Protein 90 Knockdown Promotes Cisplatin Sensitivity via Nrf2/HO-1 Pathway in Ovarian Cancer Cell. | Cancers (Basel) | 2023 | 36900383 | PubTator, text mining | PubMed |
| Editorial: Bridging the gap between immunology, virology, genetics, and epigenetics in bronchiolitis: The multiomics pathway to asthma development. | Front Immunol | 2023 | 36895569 | PubTator, text mining | PubMed |
| A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assay. | Sci Rep | 2023 | 36890145 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8932/papers?page=15